IFN intolerant in my interpretation simply means having experienced IFN previously and not having tolerated it well - this has little to do with one's IL28b status.
I agree. Furthermore Pharmasset viewed IL28b status in interferon-free therapy as being irrelevant. Patients continued to be stratified under this measure simply to appease the change-adverse mindset at the FDA.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.